GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trialsNov 1, 2019· Chuqing Cao 1st AuthorShu-Ting YANG,Zhiguang Zhou Corresponding Author· 0 min read PMID DOIpublicationLast updated on Nov 1, 2019Journal Article AuthorsShu-Ting YANGPhysicianAn endocrinologist passionate about artificial intelligence and diabetes, focusing on applying machine learning and bioinformatics to diabetes heterogeneity research. ← Multiomics-Based Colorectal Cancer Molecular Subtyping Using Local Scaling Network Fusion Dec 4, 2019A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients Sep 23, 2019 →
,